Stefan Hutzler

Paul Ehrlich Str. 51-59
Langen, NI 63225, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9.

A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9.

Journal: NPJ vaccines

Published: November 25, 2022

Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles.

Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles.

Journal: Scientific reports

Published: July 12, 2017

Development of Recombinant Measles Virus-Based Vaccines.

Development of Recombinant Measles Virus-Based Vaccines.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 05, 2017

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors.

Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors.

Journal: Molecular therapy oncolytics

Published: December 17, 2015

CD83 Modulates B Cell Activation and Germinal Center Responses.

CD83 Modulates B Cell Activation and Germinal Center Responses.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: October 06, 2015

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

Journal: Journal of virology

Published: July 16, 2015

Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.

Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response.

Journal: Journal of virology

Published: March 30, 2015

The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells.

The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 03, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026